13F-HR filed by Eversept Partners, LP
Eversept Partners, LP filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 62 holding rows worth $1,146,184,228.
- Accession
- 0001697013-23-000003
- Filer
- CIK 1697013
- Filed
- 2023-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2023
A holdings report, 62 entries on the cover page, a total value of $1,146,184,228 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,146,184,228 with VALUE read as dollars as filed, 13F file number 028-18369. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NATERA INC COM | 632307104 | Stock | 2,819,770 | $156,553,630 | dollars as filed | |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 3,731,499 | $133,929,238 | dollars as filed | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 819,124 | $89,399,193 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 6,194,572 | $54,821,962 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 222,107 | $49,743,084 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 2,209,057 | $46,655,284 | dollars as filed | |
| COMMUNITY HEALTH SYSTEMS INC | 203668108 | COMMON STOCK | 9,082,305 | $44,503,295 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 153,774 | $42,753,785 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 170,537 | $39,658,379 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 4,520,724 | $37,702,838 | dollars as filed | |
| CATALENT INC USD 0.01 | 148806102 | COM | 573,609 | $37,691,847 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 148,685 | $37,513,898 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 689,676 | $24,814,542 | dollars as filed | |
| SPDR S&P 500 ETF TR | 78462F953 | PUT | 4,100 | $21,956,873 | dollars as filed | |
| AMARIN CORPORATION PLC -ADR | 023111906 | ADR | 14,612,757 | $21,919,136 | dollars as filed | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 288,426 | $18,231,407 | dollars as filed | |
| AMEDISYS INC | 023436908 | COM | 224,263 | $16,494,544 | dollars as filed | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 76,788 | $16,401,149 | dollars as filed | |
| AVANTOR INC COM | 05352A100 | Stock | 717,614 | $15,170,360 | dollars as filed | |
| SERES THERAPEUTICS INC | 81750R102 | COM | 2,536,665 | $14,382,891 | dollars as filed | |
| BIO-TECHNE CORP | 09073M104 | COM | 188,659 | $13,996,611 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 1,788,529 | $13,878,985 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 218,726 | $11,844,013 | dollars as filed | |
| EHEALTH INC | 28238P109 | COM | 1,234,283 | $11,552,889 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 483,098 | $11,323,817 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 299,050 | $11,208,394 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 22,762 | $11,069,712 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 303,369 | $10,842,408 | dollars as filed | |
| INVESCO QQQ TR | 46090E953 | PUT | 4,500 | $10,354,065 | dollars as filed | |
| SHOCKWAVE MED INC | 82489T104 | COM | 47,577 | $10,316,121 | dollars as filed | |
| ELEVANCE HEALTH INC FORMERLY | 036752903 | CALL | 20,615 | $9,478,983 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 141,892 | $8,431,223 | dollars as filed | |
| MODEL N INC | 607525102 | COM | 241,870 | $8,095,389 | dollars as filed | |
| HCA Healthcare Inc | 40412C101 | COM | 27,909 | $7,359,045 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 203,272 | $7,275,105 | dollars as filed | |
| AMNEAL PHARMACEUTICALS INC | 03168L105 | COM STK CL A | 5,183,046 | $7,204,434 | dollars as filed | |
| PENNANT GROUP INC | 70805E109 | COM | 421,974 | $6,025,789 | dollars as filed | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 1,938,088 | $5,988,692 | dollars as filed | |
| TARO PHARMACEUTICAL INDS LTD | M8737E108 | SHS | 245,267 | $5,964,893 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 171,999 | $5,720,687 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 724,406 | $5,005,645 | dollars as filed | |
| IQVIA HLDGS INC COM | 46266C105 | Stock | 14,416 | $2,867,198 | dollars as filed | |
| HESKA CORP | 42805E306 | COM | 26,409 | $2,578,047 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 185,595 | $2,535,228 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 129,056 | $2,374,630 | dollars as filed | |
| MEDPACE HLDGS INC COM | 58506Q109 | Stock | 11,668 | $2,194,167 | dollars as filed | |
| GOHEALTH INC | 38046W204 | CL A NEW | 125,053 | $2,035,863 | dollars as filed | |
| XOMA ROYALTY CORPORATION | 98419J206 | COMMON STOCK | 89,950 | $1,898,845 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 221,551 | $1,874,321 | dollars as filed | |
| AGILENT TECHNOLOGIES INC COM | 00846U101 | Stock | 13,110 | $1,813,637 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 1,352,065 | $1,703,602 | dollars as filed | |
| REVVITY INC | 714046109 | COM | 12,335 | $1,643,762 | dollars as filed | |
| PARATEK PHARMACEUTICALS INC | 699374302 | Equity | 638,474 | $1,621,724 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 3,836 | $1,429,217 | dollars as filed | |
| AFFIMED N V | N01045108 | COM | 1,883,784 | $1,404,549 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 50,242 | $1,013,381 | dollars as filed | |
| REPLIGEN CORP COM | 759916109 | Stock | 5,656 | $952,244 | dollars as filed | |
| SPDR SERIES TRUST | 78464A950 | PUT | 800 | $838,057 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 101,918 | $737,886 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 45,856 | $608,051 | dollars as filed | |
| AMN HEALTHCARE SVCS INC | 001744951 | COM | 400 | $534,046 | dollars as filed | |
| AC IMMUNE SA | H00263105 | SHS | 124,589 | $291,538 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001697013-23-000003 | this filing | 2023-05-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001697013-23-000035 | base | 2023-11-08 | acceptance time not in the bulk data set |